BACKGROUND: To investigate monthly variation in depression, anxiety and their comorbidity (COM) in an epidemiologic study and their association to monthly variation in suicide rates. METHODS: 60,995 participants of the Health Study of Nord-Trøndelag County in 1995-97 rated themselves on the Hospital Anxiety and Depression Scale (HADS) in all months except July. All 10,670 male and 3833 female suicides in Norway from 1969 through 1996 were included. RESULTS: The prevalence of comorbid anxiety and depression was highest in spring (April, May) and in October (p<0.01). There was a correlation between the monthly variation in the national suicide rate and monthly variation in comorbid anxiety and depression (r=0.72, df=11, p=0.01) and for male alone (r=0.67, df=11, p=0.03). There was also a significant monthly variation in the prevalence of depression (p<0.001) and no monthly variation in the prevalence of anxiety. LIMITATIONS: Limited information about the third of the population who did not take part in the HUNT-2 Study. HADS based depression and anxiety cover psychological symptoms, not somatic and social ones. In relation to DSM-IV and ICD-10 defined anxiety disorders and depressions, the sensitivity and specificity of HADS caseness, give a considerable number of false-positive cases. CONCLUSIONS: Increased prevalence of comorbid depression and anxiety in males during spring, and its association with suicidality should have clinical importance, as identification and treatment could influence suicide rates.
BACKGROUND: To investigate monthly variation in depression, anxiety and their comorbidity (COM) in an epidemiologic study and their association to monthly variation in suicide rates. METHODS: 60,995 participants of the Health Study of Nord-Trøndelag County in 1995-97 rated themselves on the Hospital Anxiety and Depression Scale (HADS) in all months except July. All 10,670 male and 3833 female suicides in Norway from 1969 through 1996 were included. RESULTS: The prevalence of comorbid anxiety and depression was highest in spring (April, May) and in October (p<0.01). There was a correlation between the monthly variation in the national suicide rate and monthly variation in comorbid anxiety and depression (r=0.72, df=11, p=0.01) and for male alone (r=0.67, df=11, p=0.03). There was also a significant monthly variation in the prevalence of depression (p<0.001) and no monthly variation in the prevalence of anxiety. LIMITATIONS: Limited information about the third of the population who did not take part in the HUNT-2 Study. HADS based depression and anxiety cover psychological symptoms, not somatic and social ones. In relation to DSM-IV and ICD-10 defined anxiety disorders and depressions, the sensitivity and specificity of HADS caseness, give a considerable number of false-positive cases. CONCLUSIONS: Increased prevalence of comorbid depression and anxiety in males during spring, and its association with suicidality should have clinical importance, as identification and treatment could influence suicide rates.
Authors: Teodor T Postolache; Patricia Langenberg; Sarah A Zimmerman; Manana Lapidus; Hirsh Komarow; Jessica S McDonald; Nancy Furst; Natalya Dzhanashvili; Debra Scrandis; Jie Bai; Bernadine Postolache; Joseph J Soriano; Bernard Vittone; Alvaro Guzman; Jong-Min Woo; John Stiller; Robert G Hamilton; Leonardo H Tonelli Journal: Int J Child Health Hum Dev Date: 2008
Authors: Samantha M Garay; Katrina A Savory; Lorna A Sumption; Richard J A Penketh; Ian R Jones; Anna B Janssen; Rosalind M John Journal: Psychoneuroendocrinology Date: 2019-05-31 Impact factor: 4.905